TipRanks
Relmada Therapeutics (RLMD)
NASDAQ:RLMD
Want to see RLMD full AI Analyst Report?

Compare Relmada Therapeutics (RLMD) vs. Competitors

447 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Relmada Therapeutics
$4.59
$371.21M
-3.57
57.69%
2 Buy
0 Hold
0 Sell
Moderate Buy
XBiotech
$2.30
$66.46M
-1.46
-18.80%
―
Prelude Therapeutics
$6.34
$300.86M
-4.82
160.96%
2 Buy
0 Hold
0 Sell
Moderate Buy
Spruce Biosciences
$63.40
$130.54M
-1.05
-67.19%
6 Buy
0 Hold
0 Sell
Strong Buy
Werewolf Therapeutics
$0.89
$45.20M
-1.25
-54.68%
―

Performance Comparison

Ticker
Company Name
Price
Change
% Change
RLMD
Relmada Therapeutics
3.28
1.29
64.82%
XBIT
XBiotech
2.16
-0.48
-18.18%
RPTX
―
―
―
―
PRLD
Prelude Therapeutics
3.81
2.37
164.58%
SPRB
Spruce Biosciences
42.79
-139.82
-76.57%
HOWL
Werewolf Therapeutics
0.92
-1.01
-52.33%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts